Balanced Crystalloid Solutions for Acute Pancreatitis
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
Patients diagnosed with acute pancreatitis regardless of etiology, severity of disease, and
prior attacks will be randomized in two groups. The intervention group will receive a
balanced crystalloid (Plasmalyte) at a rate of 10 ml/kg during the first 60 min and then
continued at 3 ml/kg/h for the next 72 hours. The control group will receive normal saline at
the same rate.